Castera Mission: Provide an integrated industrial-scale solution for castor cultivation, utilizing our elite seed varieties, for bio-based industries, with a focus on biofuels
A time-limited license grant for utilizing one of Evogene’s tech-engines, to a related party for product development in a defined commercial field (In most cases the related party will be a subsidiary of Evogene).
Evogene group (NASDAQ:EVGN, TASE: EVGN) includes independently managed subsidiaries focusing on a defined commercial field with an exclusive license to use our unique solution for product development.
Each subsidiary may utilize the CPB platform capabilities to commercialize products independently or through strategic collaborations. The subsidiaries’ diverse product pipeline mitigates the risk associated with individual development and drive opportunities forward.
Castor Oil Production
Castera Mission: Provide an integrated industrial-scale solution for castor cultivation, utilizing our elite seed varieties, for bio-based industries, with a focus on biofuels
Seeds production operations
Expanding the seed production operations in several sites in Africa & Latin America, to fulfill all existing orders
Strategic alliances
Extending the collaboration frame in the biofuel space – more territories and new global partners
R&D
Developing castor varieties that meet commercially valuable traits for the Biodiesel and Sustainable Aviation Fuel (SAF) industries
Machinery
Improving mechanical harvesting solutions through collaborations with global machinery companies
Ag Biologicals
Lavie Bio Mission: Improve food quality, sustainability and agriculture productivity through microbiome based, AI-driven, ag-biological products
Bio-stimulants
Yalos™ – distribution licensing agreements and sales expansion in USA & Canada. Expansion to additional crops and an additional territory in 2025
Bio-pesticides
LAV311 - US regulatory approval for bio-fungicide candidate for fruit rots – expected by 2024;
LAV321 - submission for Lavie Bio’s bio-fungicide candidate for downy mildew to the US EPA for regulatory approval – expected by 2025;
Co-development and licensing agreement for an additional bio-pesticide program with a large multinational company – expected by 2025
Human Microbiome
Biomica Mission: Discovery and development of novel therapies for microbiome-related human disorders using computational predictive biology
Immuno-oncology
Enrollment completion & Initial clinical readout of POC from first in-human study in 2024;
Initiation of phase 2 in 2025
IBD
Clinical batch production of drug candidate for IBD as preparation for Phase 1 clinical trials in 2025
IBS
Advancement of pre-clinical studies and nomination of bacterial consortium for clinical trial
Ag-Chemicals
AgPlenus Mission: Design next-generation, effective, and sustainable crop protection products by leveraging predictive chemistry and biology
Herbicides
Corteva collaboration – Drive both projects towards next milestone;
Bayer collaboration - design additional molecules
Fungicides
Identification of 3 selected novel targets;
Generate HITs for the selected targets
Food-tech
Finally Foods is at the forefront of molecular farming, modifying plants to produce proteins for the food sector by leveraging access to the Evogene tech engine, the GeneRator AI. The company first targets casein, a key dairy and functional protein and a potato plant was chosen as the “host” to serve as the “bioreactor” to express it. Finally Foods was co-founded by a seasoned entrepreneur and by Evogene’s former VP R&D, in collaboration with The Kitchen FoodTech Hub (TKH) by Strauss Group.
Joint product development with leading companies utilizing Evogene’s unique tech-engines. Typically, the partner leads later-stage development and product commercialization.
Probiotics – Probiotics for human health
Aquaculture – Crustacean gene editing
Improved traits – Canola